Baron Asset Fund

Long-term mid-cap growth investing in competitively advantaged companies benefiting from secular growth trends and led by strong management teams.$4B AUM9 published ideas

Baron Asset Fund is a mid-cap growth fund that typically owns competitively advantaged businesses for long periods and can establish significant positions where the manager has the greatest conviction. Its portfolio combines secular growth companies across technology, communication services, industrials, financials and healthcare, with SpaceX representing an unusually large position at quarter end.

www.baroncapitalgroup.com

Ideas from Baron Asset Fund

LongAPHJun 2026

Amphenol Corporation

Amphenol's shares recovered after previously selling off on concerns that copper interconnect products could eventually be displaced by optical technologies. Baron believes…

LongPWRJun 2026

Quanta Services

Quanta provides infrastructure solutions across electric and gas utilities, renewable energy, communications, pipelines and other energy markets. Shares benefited from enthusiasm…

LongACGLJun 2026

Arch Capital Group

Arch underperformed as investors rotated away from resilient insurance stocks and property insurance pricing softened. Baron views this pricing cyclicality as normal rather than…

LongCSGPJun 2026

CoStar Group

CoStar's shares fell as fears about AI disruption caused significant multiple compression despite little evidence of a fundamental impact on the business. Baron continues to own…

LongGWREJun 2026

Guidewire Software

Guidewire declined after several new sales moved from the fiscal third quarter into the fourth quarter, which Baron views as a timing issue because those deals subsequently…

LongITJun 2026

Gartner

Gartner detracted as increasing fears about AI disruption caused its valuation multiple to compress. Baron continues to own the company because of its large addressable market…

LongCBRSJun 2026

Cerebras Systems

Baron initiated Cerebras following its IPO because it believes the company has developed one of the most differentiated architectures for fast AI inference. Demand for tokens per…

LongEWJun 2026

Edwards Lifesciences Corporation

Baron initiated Edwards Lifesciences because of its leadership in transcatheter aortic valve replacement and its emerging mitral and tricuspid valve therapies. The team believes…

Letters covered

  • Baron Asset Fund Quarterly LetterJune 30, 2026

Source PDFs are not republished here; only extracted ideas and quotes.